Welcome to our dedicated page for FB Bancorp /MD/ SEC filings (Ticker: FBLA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on FB Bancorp /MD/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into FB Bancorp /MD/'s regulatory disclosures and financial reporting.
FB Bancorp, Inc. reported that it has completed its initial stock repurchase program. The company bought back 1,983,750 shares of its common stock, equaling 10% of its then outstanding shares, at an average price of $12.725 per share including trading costs and commissions.
This repurchase reduces the company’s share count, which generally increases the ownership percentage of remaining shareholders and reflects a decision to return capital through buybacks rather than other uses.
FB Bancorp, Inc. reported a Form 4 transaction for a director dated December 10, 2025. The director received 29,756 shares of restricted common stock at a price of $0, and now directly owns 29,756 common shares, plus 10,000 shares held indirectly through an IRA. These restricted shares vest at a rate of 20% per year starting on December 10, 2026.
The director was also granted stock options on 74,390 shares of common stock with an exercise price of $13.16 per share. The options become exercisable beginning December 10, 2026, expire on December 10, 2035, and vest at 20% per year starting on December 10, 2026. The options were reported at a price of $0 for the grant itself.
FB Bancorp, Inc. reported that one of its directors received new equity awards on December 10, 2025.
The director was granted 29,756 shares of restricted common stock at a price of $0. These shares vest in 20% installments each year starting on December 10, 2026. Following this grant, the director directly beneficially owns 59,756 common shares.
The director also received stock options on 74,390 shares with an exercise price of $13.16 per share, expiring on December 10, 2035. These options vest in 20% annual installments beginning on December 10, 2026, and were reported as directly owned.
FB Bancorp, Inc. reported that a company director acquired 29,756 shares of restricted common stock on December 10, 2025 at a price of $0, resulting in 29,756 shares held directly and an additional 10,220 shares held indirectly through an IRA.
The report also shows 74,390 stock options with an exercise price of $13.16 per share, all held directly. Both the restricted shares and the options vest in equal 20% installments each year beginning on December 10, 2026, with the options expiring on December 10, 2035.
FB Bancorp, Inc. reported that one of its directors received new equity awards. On December 10, 2025, the director acquired 29,756 shares of common stock at $0, increasing directly owned shares to 79,756. These shares are restricted stock that vest at a rate of 20% per year beginning on December 10, 2026.
The director was also granted stock options for 74,390 shares of common stock at an exercise price of $13.16 per share. The options become exercisable over time, vesting 20% per year starting on December 10, 2026, and are scheduled to expire on December 10, 2035.
FB Bancorp, Inc. reported that one of its directors received new equity awards in the company’s common stock on December 10, 2025. The director was granted 29,756 shares of restricted stock at a reported price of $0, which will vest in installments of 20% per year starting on December 10, 2026.
On the same date, the director was also granted 74,390 stock options with an exercise price of $13.16 per share, vesting 20% per year beginning December 10, 2026 and expiring on December 10, 2035. Following these grants, the reporting person beneficially owns 45,756 common shares directly, 4,000 shares indirectly through an IRA, and 74,390 stock options.
FB Bancorp, Inc. disclosed that one of its directors received an equity grant. On December 10, 2025, the director acquired 29,756 shares of restricted common stock at $0 per share, bringing direct ownership to 79,756 shares. The report also shows a grant of stock options for 74,390 shares of common stock with an exercise price of $13.16, expiring on December 10, 2035. Both the restricted stock and the options vest in 20% annual installments starting on December 10, 2026.
FB Bancorp, Inc. director reported new equity awards in the company’s common stock. On 12/10/2025, the insider acquired 29,756 shares of restricted stock at a stated price of $0, bringing direct ownership to 99,756 common shares after the transaction. These restricted shares vest in installments of 20% per year starting on December 10, 2026.
The filing also shows a grant of stock options on 74,390 shares of common stock with an exercise price of $13.16 per share. The options become exercisable at a rate of 20% per year beginning on December 10, 2026 and are scheduled to expire on December 10, 2035. Both the common stock and option holdings are reported as directly owned.
FB Bancorp, Inc. reported the results of its Annual Meeting of Stockholders held on December 9, 2025. Stockholders voted on three director nominees and two additional matters. For the board nominees, Katherine A. Crosby received 8,308,790 votes for and 1,181,020 withheld, Christopher S. Ferris received 8,427,289 votes for and 1,062,521 withheld, and Stephen W. Hales received 7,695,096 votes for and 1,794,714 withheld, with 2,971,679 broker non-votes recorded for each nominee. One additional proposal received 8,287,624 votes for, 1,032,824 against, 169,362 abstentions, and 2,971,679 broker non-votes. A separate proposal received 11,604,402 votes for, 616,436 against, and 240,651 abstentions.
FB Bancorp, Inc. (FBLA) President and CEO stock purchase: A reporting person who is both a director and the President and CEO of FB Bancorp bought common stock in the company. On 11/19/2025, this insider purchased 205 shares of FB Bancorp common stock at a price of $12.03 per share, reported with transaction code "P" for a purchase.
After this transaction, the insider directly owned 5,474 shares of common stock. In addition, the filing shows indirect ownership of 30,243 shares held through a 401(k) plan and 801 shares held through an ESOP, reflecting both direct and retirement-plan-related holdings in FB Bancorp.